Advisors Preferred LLC lessened its stake in shares of Chemed Co. (NYSE:CHE – Free Report) by 11.2% in the fourth quarter, Holdings Channel reports. The institutional investor owned 835 shares of the company’s stock after selling 105 shares during the quarter. Advisors Preferred LLC’s holdings in Chemed were worth $441,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. EP Wealth Advisors LLC boosted its holdings in Chemed by 1.9% in the 3rd quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock valued at $814,000 after purchasing an additional 25 shares during the period. Ballentine Partners LLC boosted its stake in Chemed by 4.1% during the third quarter. Ballentine Partners LLC now owns 655 shares of the company’s stock valued at $394,000 after buying an additional 26 shares during the period. Creative Planning grew its position in Chemed by 2.8% during the second quarter. Creative Planning now owns 1,228 shares of the company’s stock worth $667,000 after buying an additional 34 shares in the last quarter. First Heartland Consultants Inc. increased its stake in Chemed by 7.2% in the 3rd quarter. First Heartland Consultants Inc. now owns 508 shares of the company’s stock worth $305,000 after acquiring an additional 34 shares during the last quarter. Finally, First Trust Direct Indexing L.P. raised its holdings in shares of Chemed by 4.5% in the 3rd quarter. First Trust Direct Indexing L.P. now owns 887 shares of the company’s stock valued at $533,000 after acquiring an additional 38 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $572.77, for a total value of $1,145,540.00. Following the transaction, the chief executive officer now directly owns 101,735 shares of the company’s stock, valued at $58,270,755.95. The trade was a 1.93 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Spencer S. Lee sold 732 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the sale, the executive vice president now directly owns 18,287 shares of the company’s stock, valued at approximately $10,526,362.94. This trade represents a 3.85 % decrease in their position. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by insiders.
Chemed Stock Performance
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on CHE shares. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th. Royal Bank of Canada dropped their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th.
Get Our Latest Analysis on CHE
Chemed Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
See Also
- Five stocks we like better than Chemed
- Stock Splits, Do They Really Impact Investors?
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- Pros And Cons Of Monthly Dividend Stocks
- MarketBeat Week in Review – 02/03 – 02/07
- The 3 Best Fintech Stocks to Buy Now
- Meta Platforms Continues to Prove Why It’s a Premier Play on AI
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.